NCT05810935

Brief Summary

this study will be conducted to assess the knowledge of the pregnant females regarding safety of antibiotic intake ,also their attitude toward any prescribed antibiotics during their pregnancy .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
384

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 13, 2023

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

April 13, 2023

Status Verified

April 1, 2023

Enrollment Period

8 months

First QC Date

March 29, 2023

Last Update Submit

April 11, 2023

Conditions

Keywords

antibiotics, infection

Outcome Measures

Primary Outcomes (1)

  • Number of participants with antibiotic-related side effects

    using a questionnaire to measure the knowledge and attitude of pregnant women toward antibiotics that were taken during pregnancy and any malpractice during its intake

    through study completion ,an average of one year

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

this study is an observational cross sectional study that will be conducted on pregnant female above the age of 18 years old iwith exclusion of any female with any psychological disability.

You may qualify if:

  • pregnant women at any gestational age

You may not qualify if:

  • pregnant women who refused to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infections

Central Study Contacts

Eman Ibrahim Abd Elrehim, Lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Department of obstetrics and gynecology, Damietta Faculty of Medicine, Al-Azhar University

Study Record Dates

First Submitted

March 29, 2023

First Posted

April 13, 2023

Study Start

May 1, 2023

Primary Completion

January 1, 2024

Study Completion

May 1, 2024

Last Updated

April 13, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share